| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 07/29/2004 | WO2003054177A3 New glycosyl hydrolases |
| 07/29/2004 | WO2003054155A3 Pichia pastoris formate dehydrogenase and uses therefor |
| 07/29/2004 | WO2003044176A3 Functional polymorphisms of the interleukin-1 locus affecting transcription and susceptibility to inflammatory and infectious diseases |
| 07/29/2004 | WO2003034029A3 Multiplexed analysis of polymorphic loci by concurrent interrogation and enzyme-mediated detection |
| 07/29/2004 | WO2003025150A3 Lipid-associated molecules |
| 07/29/2004 | WO2003022123A3 Methods of kidney transplantation utilizing developing nephric tissue |
| 07/29/2004 | US20040148667 by phenotypic analysis, genetic mapping and marking by means of transposons; for inducing an apomictic development in sexual plants (corn) |
| 07/29/2004 | US20040148666 Cotton event PV-GHGT07(1445) and compositions and methods for detection thereof |
| 07/29/2004 | US20040148649 for plants cells, tissue or entire plants (maize, tobacco, alfalfa, rice, soybean, pea, wheat, barley, sunflower, potato, tomato, and cotton) which comprise a coding region for herbicide/insect/drought/cold resistance |
| 07/29/2004 | US20040147904 Methods and devices for delivery of agents to breast milk ducts |
| 07/29/2004 | US20040147734 Nucleic acid and amino acid sequences relating to staphylococcus epidermidis for diagnostics and therapeutics |
| 07/29/2004 | US20040147728 Method for increasing hydrophilicity of fluorescent label compounds |
| 07/29/2004 | US20040147724 for diagnosis/treatment of cancer, myeloproliferative disorders, angiogenesis, obesity, osteoporosis, non-insulin dependent diabetes, lipid metabolism disorder, hypercalcemia, hypercholestrolemia; genetic engineering |
| 07/29/2004 | US20040147596 Antidiabetic agents; immunology diseases; antiinflammatory agents |
| 07/29/2004 | US20040147540 Compositions and methods for inhibiting platelet activation and thrombosis |
| 07/29/2004 | US20040147470 Nuclease resistance; for therapy and prophylaxis of disease |
| 07/29/2004 | US20040147468 Immunostimulatory nucleic acid molecules |
| 07/29/2004 | US20040147432 Melanin-concentrating hormone analogs |
| 07/29/2004 | US20040147041 comprises a test chamber formed by a base part and a head part and means for moving the sample in the test chamber pumps are connected via channels a portion of the sample liquid is alternately drawn off and supplied back |
| 07/29/2004 | US20040147031 having a coating layer on the surface with nanoparticles present, enabling the functional beads to emit light specific to the nanoparticles by applying a voltage to the functional beads in flow path; flow cytometry |
| 07/29/2004 | US20040147022 comprising at least a portion of a RNA-induced silencing complex (RISC); gene expression inhibition; genetic engineering |
| 07/29/2004 | US20040147011 High growth methanotrophic bacterial strain |
| 07/29/2004 | US20040147004 Comprises nucleotide sequences coding enzymatic polypeptide for use as tool in identifying modulators for diagnosis, treatment and prevention of cancer and cell proliferative disorders |
| 07/29/2004 | US20040147003 Comprises nucleotide sequences coding kinase for use as tool in identifying modulators for treatment and prevention cell proliferative disorders |
| 07/29/2004 | US20040146988 Interferon-like protein zcyto21 |
| 07/29/2004 | US20040146987 Nucleotide sequences coding chloramphenicol acetyltransferase, luciferase, beta-glucuronidase or beta-galactosidase gnetically engineered fusion polypeptide with reduced half-life of expression; diagnostic tools for genetic and disease analysis |
| 07/29/2004 | US20040146986 Nucleotide sequences coding transcription factor associated with tumor suppressor activity for use in treatment and prevention of cell proliferative disorders |
| 07/29/2004 | US20040146981 DNA encoding human serine protease D-G |
| 07/29/2004 | US20040146976 Transforming microorganism and monitoring expression of heterologous proteins on cell surface; monitoring protein-protein interactions and identifying modulators for treating autoimmune and cell proliferative diseases |
| 07/29/2004 | US20040146972 Humanized polynucleotide sequence encoding renilla mulleri green fluorescent protein |
| 07/29/2004 | US20040146965 Petri dish |
| 07/29/2004 | US20040146964 Assays, methods and means |
| 07/29/2004 | US20040146963 High throughput assays for the proteotytic activities of clostridial neurotoxins |
| 07/29/2004 | US20040146961 fluorescence resonance energy transfer; for high throughput screening and drug screening/targets for anticancer agents |
| 07/29/2004 | US20040146960 Methods for the identification of inhibitors of Trehalose-6-Phosphate Synthase as antibiotics |
| 07/29/2004 | US20040146959 for detecting the phosphorylation activity of one or more protein kinases in a sample; fluorescent dye linked phosphorylable substrate |
| 07/29/2004 | US20040146957 Biosensor |
| 07/29/2004 | US20040146956 Protease efc cell surface fusion protein assay |
| 07/29/2004 | US20040146955 CA IX-specific inhibitors |
| 07/29/2004 | US20040146953 Assay |
| 07/29/2004 | US20040146946 used to study oxidative stress-related disorders and diseases and drug screening treatments for Alzheimer's disease |
| 07/29/2004 | US20040146945 used to study oxidative stress-related disorders and diseases and drug screening treatments for Alzheimer's disease |
| 07/29/2004 | US20040146942 for drug screening in vivo/vitro gene therapy for inflammatory/persistent pain; animal models; genetic engineering |
| 07/29/2004 | US20040146938 Methods of generating and screening for proteases with altered specificity |
| 07/29/2004 | US20040146935 Disease associated gene |
| 07/29/2004 | US20040146933 Latent human tuberculosis model, diagnostic antigens, and methods of use |
| 07/29/2004 | US20040146931 for detecting protein-protein, protein-DNA, or protein-RNA interactions; for drug screening or screening libraries with greater than 107 members; used in conjunction with flow cytometry; solid phase synthesis; kits |
| 07/29/2004 | US20040146930 for diagnosing susceptibility to a pathological condition based on the presence or absence of mutation; drug screening; genetic engineering |
| 07/29/2004 | US20040146929 for drug screening, in vitro or in vivo diagnosis, and gene therapy; antitumor agents; genetic engineering; kits |
| 07/29/2004 | US20040146925 for diagnosis and targeted drug delivery for blood cancer and monitoring protein expression or activity of white blood cells in vitro |
| 07/29/2004 | US20040146922 on a genome-wide scale using a genome-registered gene fusion collection, which are amenable to rapid assay and may be used to confirm, correct or augment data generated |
| 07/29/2004 | US20040146921 Expression profiles for colon cancer and methods of use |
| 07/29/2004 | US20040146919 comprises staining tissues and genetic analysis to determine whether the DNA of such sites exhibits allelic losses for mutation of tumor suppressor genes; genetic engineering |
| 07/29/2004 | US20040146918 Hybrid nucleic acid assembly |
| 07/29/2004 | US20040146917 Nanoparticle imaging system and method |
| 07/29/2004 | US20040146916 Biochip |
| 07/29/2004 | US20040146915 by contacting the nucleic acid sample with a primer pair that generate different sized amplification products depending on whether an X chromosome or a Y chromosome copy of the canine amelogenin gene is amplified |
| 07/29/2004 | US20040146912 correlated with the presence of breast cancer in a human with blood tests; restriction enzymes; polymerase chain reaction (PCR); kits |
| 07/29/2004 | US20040146911 Method for the uncoupled, direct, exponential amplification and sequencing of DNA molecules with the addition of a second thermostable DNA polymerase and its application |
| 07/29/2004 | US20040146910 Methods of genetic analysis of rat |
| 07/29/2004 | US20040146909 comprises array with a plurality of electrodes, a capture binding ligand covalently attached to the electrode, a target analyte, and an electron; for higher signal to noise ratios/detection limits; includes monitoring at higher harmonic frequencies |
| 07/29/2004 | US20040146908 Fibroblast growth factor-19 (FGF-19) nucleic acids and polypeptides and methods of use for the treatment of obesity and related disorders |
| 07/29/2004 | US20040146907 Methods and compositions for detecting dysplasia |
| 07/29/2004 | US20040146905 Genetic sequences, diagnostic and/or quantification methods and devices for the identification of staphylococci strains |
| 07/29/2004 | US20040146904 Vascular-preferred promoter sequences and uses thereof |
| 07/29/2004 | US20040146903 Methods and compositions for modulating activator protein 1 |
| 07/29/2004 | US20040146902 oligomer complementary to and capable of hybridizing to a selected target nucleic acid and at least one protein comprising at least a portion of an RNA-induced silencing complex |
| 07/29/2004 | US20040146901 Selecting tag nucleic acids |
| 07/29/2004 | US20040146900 Using presence/absence of polymorphism in ataxia polypeptide and/or genes to diagnose myoclonus, dystonia, epilepsy and nystagmus |
| 07/29/2004 | US20040146899 Recovering and analyzing blood using monolayers comprised of insulators and/or electroconduit-forming species; nucleic acid and protein screening; diagnosing infection |
| 07/29/2004 | US20040146898 Microsatellite markers for plants of the genus triticeae and use thereof |
| 07/29/2004 | US20040146897 Method for performing multiplex PCR with cyclic changes of PCR parameters |
| 07/29/2004 | US20040146896 Methods and compositions for diagnosing and treating companion animal cancer |
| 07/29/2004 | US20040146895 useful in detection and isolation of target analytes such as biomolecules |
| 07/29/2004 | US20040146894 Methods of diagnosing and treating stress urinary incontinence |
| 07/29/2004 | US20040146892 Expression vector coding organelle transport protein for use in identifying modulators of adenine nucleotide translocator and cyclophilin d interaction |
| 07/29/2004 | US20040146890 Method for genotyping polymorphisms in humans |
| 07/29/2004 | US20040146889 Inducible regulatory system and use thereof |
| 07/29/2004 | US20040146888 Cystine-knot polypeptides: cloaked-2 molecules and uses thereof |
| 07/29/2004 | US20040146886 DNA probes, method and kit for identifying antibiotic-resistant strains of bacteria |
| 07/29/2004 | US20040146885 Multiplexing array techniques |
| 07/29/2004 | US20040146883 Methods for prenatal diagnosis |
| 07/29/2004 | US20040146882 Human acid sensing ion channel 2b (hASIC2b), process for producing the same, and its use |
| 07/29/2004 | US20040146881 Species specific DNA detection |
| 07/29/2004 | US20040146880 Diagnosing metabolic disorders via presence of polymorphism in specific genetic loci; genetic mapping; genotyping bioassay |
| 07/29/2004 | US20040146879 Novel human genes and gene expression products |
| 07/29/2004 | US20040146878 Identifying muscular disorder using amplified mutant gene sequences; genetic mapping |
| 07/29/2004 | US20040146877 Diagnosis and treatment of cancer:I |
| 07/29/2004 | US20040146876 Complex element micro-array and methods of use |
| 07/29/2004 | US20040146875 Detecting nucleotide sequence variation between alleles/heteroduplex DNA; restriction fragment length polymorphisms |
| 07/29/2004 | US20040146874 Disposable biochip for determining nucleotide sequence beyond specified primer; DNA sequencing and analysis |
| 07/29/2004 | US20040146873 Advanced sleep phase syndrome gen in humans |
| 07/29/2004 | US20040146872 Comprises nucleotide sequences coding delta-2-enoyl-coA isomerase for use in identifying modulators for treatment and diagnosis of inflammatory, cardiovascular, skin, body weight and cancer disorders |
| 07/29/2004 | US20040146871 Beadmilling the sample in a beadmilling buffer to disrupt cells in the sample and extracting RNA, DNA or protein from the sample using a solid phase extraction; ribonuclease inhibitor in the beadmilling buffer is guanidium isothiocyanate |
| 07/29/2004 | US20040146870 Correlating phenotypic characteristic/polymorphisms with position on genetic physical map using haplotype genomes |
| 07/29/2004 | US20040146868 Using peptide nucleic acids as probes for monitoring differential methylation of gluthione s-transferase p gene and diagnosing cell proliferative disorders |
| 07/29/2004 | US20040146867 Compounds and processes for single-pot attachment of a label to siRNA |
| 07/29/2004 | US20040146866 Quantitative multiplex detection of nucleic acids |
| 07/29/2004 | US20040146865 Use of haploid genomes for genetic diagnosis, modification and multiplication |
| 07/29/2004 | US20040146864 Joining DNA sequences using topoisomerase I |